The role of CD4 + FoxP3 + regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment
COVID-19의 면역 병인 발생에서 CD4 + FoxP3 + 조절 T 세포의 역할: 치료에 대한 의미
Review
[키워드] “cytokine storm”
acute respiratory distress
acute respiratory distress syndrome
acute respiratory syndrome
acute respiratory syndrome coronavirus
adalimumab
addressed
Antiviral
ARDS
attenuation
Azithromycin
CD4
CD4+FoxP3+ regulatory T cells
Chloroquine
Coagulopathy
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
cytokine
Cytokine release syndrome
Cytokine storm
Defense
deficiencies
deficiency
Dexamethasone
early stage
FOXP3
Hydroxychloroquine
IL-2
immune
Immune homeostasis
immune response
immune responses
Immunopathogenesis
immunopathology
implication
Infection
Inflammatory responses
introduced
involved
late stage
low dose
maintenance
mechanisms
organ damage
organ injury
Patient
Perspective
problem
problems
Regulatory
Regulatory T cell
regulatory T cells
respiratory
respiratory distress
Respiratory distress syndrome
sarilumab
SARS-CoV-2
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
Severe case
severe cases
syndrome
T cell
T cells
tetrandrine
therapeutic agent
therapeutic agents
Therapies
Tocilizumab
transfer
Treatment
Treg
Treg cell
Treg cells
Tregs
Vitamin D
[DOI] 10.7150/ijbs.59534 PMC 바로가기 [Article Type] Review
[DOI] 10.7150/ijbs.59534 PMC 바로가기 [Article Type] Review